Duyuru • 5h
XIIlab Co.,Ltd to Report Q1, 2026 Results on May 28, 2026 XIIlab Co.,Ltd announced that they will report Q1, 2026 results at 2:00 PM, Korea Standard Time on May 28, 2026 New Risk • Apr 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (54% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩64.6b market cap, or US$43.9m). Duyuru • Feb 13
XIIlab Co.,Ltd, Annual General Meeting, Mar 30, 2026 XIIlab Co.,Ltd, Annual General Meeting, Mar 30, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 513, yeongdong-daero, gangnam-gu, seoul South Korea New Risk • Aug 30
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 54% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 9.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (54% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩48.4b market cap, or US$34.9m). Duyuru • Aug 16
XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 36.772394 billion. XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 36.772394 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 3,050,068
Price\Range: KRW 5800
Discount Per Security: KRW 104.4
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 3,290,000
Price\Range: KRW 5800
Discount Per Security: KRW 104.4
Transaction Features: Rights Offering New Risk • Jul 01
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 17% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩49.2b market cap, or US$36.4m). New Risk • May 22
New major risk - Revenue and earnings growth Earnings have declined by 17% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (₩40.7b market cap, or US$29.5m). Duyuru • May 15
XIIlab Co.,Ltd has filed a Follow-on Equity Offering in the amount of KRW 17.8647 billion. XIIlab Co.,Ltd has filed a Follow-on Equity Offering in the amount of KRW 17.8647 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 3,290,000
Price\Range: KRW 5430
Discount Per Security: KRW 97.74
Transaction Features: Rights Offering Reported Earnings • Mar 20
Full year 2024 earnings released: ₩851 loss per share (vs ₩1,063 loss in FY 2023) Full year 2024 results: ₩851 loss per share (improved from ₩1,063 loss in FY 2023). Revenue: ₩9.09b (up 148% from FY 2023). Net loss: ₩5.19b (loss narrowed 20% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 33% per year, which means it is performing significantly worse than earnings. Duyuru • Feb 25
XIIlab Co.,Ltd, Annual General Meeting, Mar 26, 2025 XIIlab Co.,Ltd, Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 513, yeongdong-daero, gangnam-gu, seoul South Korea Reported Earnings • Aug 17
Second quarter 2024 earnings released: ₩307 loss per share (vs ₩268 loss in 2Q 2023) Second quarter 2024 results: ₩307 loss per share (further deteriorated from ₩268 loss in 2Q 2023). Revenue: ₩348.2m (up 3.2% from 2Q 2023). Net loss: ₩1.87b (loss widened 15% from 2Q 2023). Reported Earnings • Mar 22
Full year 2023 earnings released: ₩1,063 loss per share (vs ₩754 loss in FY 2022) Full year 2023 results: ₩1,063 loss per share (further deteriorated from ₩754 loss in FY 2022). Revenue: ₩3.66b (down 63% from FY 2022). Net loss: ₩6.46b (loss widened 42% from FY 2022). Duyuru • Mar 20
Xiilab Unveils Cutting-Edge AI Technologies At NVIDIA GTC Xiilab announced its participation in the global AI conference, NVIDIA GTC, held in San Jose, California, USA, and online from March 18th to 21st, 2024. Xiilab plans to showcase its AI technology at GTC through three main products: AI video analysis service ('VidiGo'), synthetic data generation solution ('X-GEN'), and GPU orchestration solution. The first product, 'VidiGo,' is a cloud-based AI video analysis service that accurately summarizes the core contents of a video without watching it. It can also quickly search for desired video scenes. Users can easily make a database of characters, objects, and dialogues in the video, which significantly improves work efficiency in the media industry. The second product, 'X-GEN,' is a solution for generating synthetic data for AI model training. Especially in areas like disaster response or defense, there is a shortage of data for AI training. X-GEN can provide synthetic data which can replace real data in such rare conditions, even maximizing AI training performance. Xiilab has been applying 'X-GEN' in the digital twin field using the NVIDIA Omniverse. platform, which provides 3D-workflow and simulation capabilities. Since 2023, Xiilab has been successfully leading digital twin construction projects for global companies. Finally, Xiilab will introduce its GPU efficiency enhancement solution 'astrago' at GTC. Equipped with AI training time prediction technology and AI model management capabilities, 'astrago' is designed to optimize GPU utilization. It predicts the usage time of GPUs and combines AI models suitable for specific services, which can maximize GPU efficiency. Users can significantly reduce the costly expenses associated with GPU usage. New Risk • Nov 12
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2022 fiscal period end). Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 32% over the past year. Minor Risk Market cap is less than US$100m (₩69.5b market cap, or US$52.7m). New Risk • Jul 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue has declined by 32% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported September 2022 fiscal period end). Market cap is less than US$100m (₩80.3b market cap, or US$62.8m). Is New 90 Day High Low • Feb 26
New 90-day low: ₩36,750 The company is down 8.0% from its price of ₩40,000 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 9.0% over the same period. Duyuru • Feb 25
XIIlab Co.,Ltd, Annual General Meeting, Mar 25, 2021 XIIlab Co.,Ltd, Annual General Meeting, Mar 25, 2021, at 10:00 Korea Standard Time. Is New 90 Day High Low • Jan 19
New 90-day high: ₩72,000 The company is up 125% from its price of ₩32,050 on 21 October 2020. The South Korean market is up 26% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 10.0% over the same period. Is New 90 Day High Low • Dec 22
New 90-day high: ₩43,700 The company is up 36% from its price of ₩32,200 on 23 September 2020. The South Korean market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 9.0% over the same period. Is New 90 Day High Low • Nov 27
New 90-day high: ₩40,000 The company is up 56% from its price of ₩25,600 on 28 August 2020. The South Korean market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 3.0% over the same period. Duyuru • Jul 17
XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 799.94712 million. XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 799.94712 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 50,122
Price\Range: KRW 15960
Transaction Features: Subsequent Direct Listing 